US Stock MarketDetailed Quotes

BDTX Black Diamond Therapeutics

Watchlist
  • 6.190
  • +0.280+4.74%
Trading Jul 23 11:28 ET
348.30MMarket Cap-3728P/E (TTM)

Black Diamond Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Black Diamond Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.35

+38.60%
Analyst Rating

Strong Buy

Jul 8, 2024

Black Diamond Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Black Diamond Therapeutics Earnings Reports

  • Black Diamond Therapeutics | 10-Q: Quarterly report

    May 9 07:17 ET

  • Black Diamond Therapeutics | 10-K: Annual report

    Mar 12 07:22 ET

  • Black Diamond Therapeutics: Q3 2023 Earnings Report

    Nov 6, 2023 07:14 ET

  • Black Diamond Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 11, 2023 07:26 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 8, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg